snn0031
Small moleculeexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2009 (NCT00866502)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- snn0031
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02408562 | Phase 1/Phase 2 (Phase 2) | Jan 31, 2015 | European Union, Lund University, Newron Pharmaceuticals |
| NCT01829867 | Phase 1 | Apr 1, 2013 | Newron Pharmaceuticals |
| NCT00866502 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2009 | IQVIA, Karolinska Institute, Medtronic, Newron Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Newron Pharmaceuticals | For profit | 3 | 3 | 2 | 2009 |
| European Union | Government | 1 | 0 | 1 | 2015 |
| IQVIA | For profit | 1 | 0 | 1 | 2009 |
| Karolinska Institute | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Lund University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Medtronic | For profit | 1 | 0 | 1 | 2009 |
6 organizations
Page 1 / 1